I had a wide-ranging conversation with Marc Iskowitz (whom you may remember leading editorial pursuits at MM&M, now playing lead editor role at Beghou Consulting. Here’s a link to Marc’s insights gleaned from several of us industry analyst-types looking through various lenses on how tariffs could re-shape the pharmaceutical industry within the U.S. and globally.
Jane’s insights into tariffs & pharma with Marc Iskowitz, Editorial Director of Beghou Consulting
By Jane Sarasohn-Kahn on 21 July 2025 in
Thank you Aaron Strout for hosting our conversation on the Reaching Higher Podcast, now live on Apple, Spotify, and YouTube. We covered a lot of ground addressing health care and health citizenship, the growing prospects for our homes as our health hubs, and how our humanity is a key ingredient in health-making for all.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global pharmaceutical company.
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance. Click onto the Pfizer Value of Vaccines site and you can watch four episodes covering the challenges with adult vaccination, the employer and health plan member's journey to vaccination, reimbursement, and collaborating for proactive prevention.